Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-02 Purchase | 2021-12-06 5:31 pm | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 34,326 | $12.82 | $440,059 | 14,186,922 (Indirect) | View |
| 2021-11-30 Purchase | 2021-12-02 5:24 pm | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 97,151 | $12.24 | $1,189,199 | 14,186,126 (Indirect) | View |
| 2021-11-26 Purchase | 2021-11-30 5:26 pm | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 68,523 | $11.64 | $797,426 | 14,183,872 (Indirect) | View |
| 2021-06-02 Purchase | 2021-06-04 5:01 pm | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 600,000 | $20 | $12,000,000 | 16,114,101 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-21 Other | 2022-03-23 4:36 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 1,839,265 | $0 | 10,605,119 (Indirect) | View |
| 2021-06-02 Conversion | 2021-06-04 5:01 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 1,931,818 | $0 | 16,114,101 (Indirect) | View |
| 2021-01-29 Option Award | 2021-06-04 5:01 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 1,931,818 | $11 | 16,114,101 (Indirect) | View |
Ownership | 2021-05-27 8:20 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 0 | $0 | 17,323,892 (Indirect) | View |